On December 11, 2002, Mississauga, Ontario-headquartered Biovail Corporation acquired Irvine, California-based Pharma PASS LLC, and Pharma PASS SA, based in France, both of which belong to the Pharma PASS group. Pharma PASS is a developer of advanced oral controlled release technologies and formulations. Both companies were purchased for a total purchase price of approximately US$190 million.
Biovail was represented in-house by Mark Thompson, associate general counsel; in Canada, by Osler, Hoskin & Harcourt LLP with a team that included Doug Marshall and François Janson (corporate) and Richard Tremblay and Julie Colden (tax); in the U.S., by Bill Schrieber of Fenwick & West LLP; and in France, by Pascal Chadenet and Jérome Gandon of Salans. Pharma PASS was represented by Harold Nelson of Nelson and Associates.